Instructions for Integrated Care Pathway use
|
|
- Brittany Simpson
- 5 years ago
- Views:
Transcription
1 αβχ Instructions for Integrated Care Pathway use This pathway is to be used in place of all previous documentation for patients with a Deep Vein Thrombosis (DVT). It is to be used by Emergency Department doctors and Anticoagulant Nurse Practitioner(s) to assess and treat (see relevant PGDs) outpatients with a proven DVT. It is a legal document, therefore all entries on the pathway, must be signed for with the date and time of entry Where possible the pathway has been based on clinical evidence. Where no evidence is available, a decision has been made to use best clinical practise. The pathway is a prompt only, any deviations from the pathway, must be written into the pathway along with any action taken and the results of the action. The variance must also be signed. This process enables the practitioner to use their clinical judgement and also enables the pathway to be audited more easily. The pathway follows the patient throughout their treatment. To use the pathway, just follow the prompts, fill in the relevant spaces, add any variances and then sign at the bottom of the sheet, to indicate that you have completed the pathway of care. Abbreviations used: Appt = Appointment MAU = Medical admissions unit B.P. = Blood pressure Min = Minute D.V.T = Deep Vein Thrombosis 02 = Oxygen E.D = Emergency Department P.E = Pulmonary embolism e.g. = for example POP = Plaster of Paris G.P. = General Practitioner Pt = Patient G.I. = Gastro Intestinal Resps = Respiration Hb = Haemoglobin S/C = Subcutaneous ICP = Integrated Care Pathway S.O.B = Short of Breath IU = International Units Tel no = Telephone Number INR = International Normalised USS = Ultra sound scan Ratio -ve = negative Kg = Kilograms +ve = positive l = litres V.A.U = Vascular assessment unit LMWH = Low Molecular Weight Heparin If you have any problems with this pathway. Please contact Elaine Willman ext 4442, or Liz Murray - Anticoagulant Nurse Specialist ext 4006 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04
2 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Radiologist Written Report (please affix printed sheet or hand write report) If a positive DVT, is the Arterial Wave form at the ankle triphasic / biphasic / monophasic? C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 2 Nov04
3 Dr or Nurse Practitioner follow steps 1-6 Nurse Discharging Patient follow step 7 Treat ALL occlusive DVT s with anticoagulation. Non occlusive below knee DVT s need Aspirin and a repeat scan in 10 days (if already taking Aspirin please discuss with E.D. Senior) Step 1. Ensure patient has had LFT s. FBC, INR and U&E s taken and sent to the lab Step 2. Is the patient suitable for Out Patient treatment? All answers must be No to proceed to Out Patient Treatment REASONS FOR ADMISSION Yes No Suspected / confirmed Pulmonary emboli Significant swelling above knee, suggestive of iliac thrombus or vena cava thrombus Active bleeding e.g. intracranial bleed within the last 6 months, G.I. bleed within 1 month, oesophageal varices, macroscopic haematuria within 1 month Verified bleeding disorders e.g. haemophilia, platelets <100 Renal failure with serum creatinine >300mmols/ltre History of hypersensitivity to heparin, heparin induced thrombocytopenia, heparin induced thrombosis Baseline INR >1.4 or / and abnormal LFT s Other evidence of chronic Liver Disease Pregnant patients - refer to Haematologist Likelihood of non-compliance e.g. dementia, drug addiction, unable to self medicate safely C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04
4 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Step 3 Presenting complaint: SOB? Chest Pain? Past Medical History: Medication: Allergies: Systemic Enquiry: Yes/ No Social History: Unexplained weight loss Anorexia Night Sweats Bowel Habit note changes Urinary problems Post menopausal bleeding If suspect occult carcinoma arrange urgent follow up OPA 2/52 OBSERVATIONS Thigh Measurement: Right Left Temp oc Calf Measurement: Right Left Pulse B.P. Affected Leg: Resps 02 Sats Pain Heat Weight Kgs Other examination findings: C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 4 Nov04
5 Sign /Status/ Date & time: Step 4 Document blood results here. If abnormal discuss with Senior Dr before prescribing Warfarin Blood results: Hb g/dl Creatinine mol/l WBC x10/l INR Platelets x10/l LFT s Urea mmol/l D.Dimer Recommendations for Anticoagulant Treatment DVT Length of treatment Therapeutic Range Post op calf 6weeks Spontaneous calf 3 months Proximal 6 months Recurrent (not taking warfarin)? long term(consider thrombophilia screen) Recurrent (taking warfarin) Long term (refer to physicians) Taken from Guidelines on Oral Anticoagulation prepared by the Haemostasis and Thrombosis Task force Reference BJH, 1998,101, Anticoagulant Nurse Practitioner to supply prescription against Patient Group Direction or E.D Dr to write prescription for 28 x 1mg Warfarin tablets 28 x 3mg Warfarin tablets Dalteparin (dose according to weight) S/C OD for 5 days. (Pre-labelled boxes of these drugs are stocked in SSEU drug cupboard) Give patient yellow anticoagulation book with written instructions for loading dose of warfarin (normally 10mg, 10mg & 5mg of warfarin over 3 days). Warfarin should only be started on Mondays, Tuesdays & Fridays to tie in with Anticoagulation Clinic for 1 st INR. Patient to attend Anticoagulation Clinic in Pathology Reception between 9am & 10am on 4 th day of warfarin treatment (do not need appointment but will need to bring yellow anticoagulation book with them) & to ask to see Anticoagulation Nurse. Dalteparin Doses USE ONLY FIXED DOSE PRE-FILLED SYRINGES Weight Dose < 46Kg 7,500iu 46-56kg 10,000iu 57-68kg 12,500iu 69-82kg 15,000iu >83kg 18,000iu C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04
6 Step 5 Dr to complete Anticoagulant Service Referral Form Patient Details: Hospital no. Surname Previous surname Date of birth Post Code Referral Details: Referring clinician GP Practice/ Ward / Clinic Date of referral Date of consultation Dear Doctor / Nurse Practitioner NHS no. Forenames Title Home tel. no. Work tel. no. Mobile no. Sex Preferred clinician (if applicable) New referral? Yes Rereferral? Date last seen Dates not available The above patient requires anticoagulation with warfarin for treatment of (please tick): Deep vein thrombosis Prophylaxis of DVT Pulmonary embolism Myocardial infarction Recurrent DVT/PE Transient ischaemic attack Prosthetic heart valve CABG Atrial fibrillation Arterial disease Other (please describe) Proposed duration of treatment is: 3 months 6 months 12 months Long term Other Desired therapeutic range: INR INR Other Treatment of DVT and PE Systemic embolism Prevention of venous thromboembolism after MI Mitral stenosis with embolism AF Transient ischaemic attacks Xenograft or homograft heart valve replacements ( for Carbomedics valve replacements) Does patient have? Liver disease/alcoholism Malabsorption Renal failure Please list all concomitant medication Recurrent DVT and PE Mechanical prosthetic heart valves Arterial disease including MI Cardiac failure Peptic ulcer Mental impairment Should patient stop any medication before starting warfarin?. Has patient started warfarin?* Yes/ No Date prescription issued (the referring doctor must supply all patients with a prescription of warfarin) For non-urgent warfarinisation it is preferable to allow the clinic to commence warfarin, so that blood tests can be co-ordinated with clinic days. * If yes, please state doses already given (for patients being discharged from hospital, please ensure that inpatient anticoagulant record accompanies this form): Date INR Dose Date INR Dose Date INR Dose Date INR Dose No Signed Date C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 6 Nov04
7 For further assistance please contact the anticoagulant nurse or Dr Jonathan Cullis ext 4828 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04
8 Step 6 assessing Dr must complete this and send to GP αβχ DOB (or affix patient label) Emergency Department/ Short Stay Emergency Unit Date: / / GP details:.. PATIENT DISCHARGE SUMMARY Deep Vein thrombosis Dear Dr Your patient attended the Emergency Department and was diagnosed with the following:- Above knee DVT Occlusive DVT Diagnosis Below knee DVT Non occlusive DVT Treatment Your patient has/ has not commenced anticoagulation treatment Predisposing factors:- As no cause for the patient s DVT has been identified please would you ensure that your patient has a general health screen within the next month. Waveform from Duplex scan is Monophasic please do not prescribe compression hosiery Biphasic / Triphasic please prescribe compression hosiery Your patient has / has not been referred to the physicians for follow up If your patient requires a Thrombophilia screen, this will be arranged by the anticoagulant clinic at the end of anticoagulation treatment Additional Comments Thank you Signed Designation Please give a copy of the letter to the patient C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 8 Nov04
9 αβχ Attach Patient Label Here D.V.T. Pathway Hospital Number Step 7 Nurse to complete the following discharge procedure Subject Discuss diagnosis with patient / relatives and give patient information leaflet. Comments Does patient need additional social care? Medications given to patient Yes / No Patient aware of need to obtain Compression Stockings from G.P. /Community Nurse Comments: Patient taught to self administer Dalteparin Relative / carer taught to administer Dalteparin Referral to District Nurse /Practise nurse for daily Dalteparin Community Nurse letter completed and given to the patient Patient given sharps bin and instruction for use Yes / No Yes / No Yes / No Yes / No Yes / No Dalteparin Record of Administration Dalteparin S/C Dose Given by Batch Number Date Time Site of injection VARIANCE RECORDING SHEET DATE TIME VARIANCE/ REASON ACTION TAKEN AND RESULT FROM ACTION SIGN C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc Nov 04
10 αβχ Date / / Community Nurse DISCHARGE SUMMARY Deep Vein thrombosis Anticoagualtion Service DOB Salisbury District Hospital Salisbury Wiltshire SP2 8BJ (or affix patient label) Tel GP Dear Community Nurse/Practice Nurse The above patient has been diagnosed with a DVT and has commenced Anticoagulation treatment with Dalteparin and Warfarin. As the patient is unable to self-inject could you please ensure that the Dalteparin is given as per the following instructions: Day, Date & Time Dose of Dalteparin Injection site Batch No Exp date Given by The patient is due to start Warfarin as follows: Day & Date Dose of Warfarin to be 6pm The patient needs to have their first INR taken on.. and have been given an appointment to attend the Anticoagulant Clinic at Salisbury District Hospital. The patient needs to have their first INR taken on.. but is unable to attend the Anticoagulant Clinic at Salisbury District Hospital. Please would you could take the INR in the community and send it to us. Many thanks for your assistance. Drs Signature Date and time Note for the Patient: If you have not heard from the community nurse by 5pm on the day that you are expecting your injection, please phone either of the following numbers and speak to someone who can help you to contact the community nurse. The numbers are: Twilight Nurses (mobile ) or Hants patients ext 6308, Dorset ext 6305 C:\WebDev\pbc_support\source\bracknell\Clinical Pathways\Integrated Care Pathway.doc - 10 Nov04
Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved
Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust Venous. Thromboembolism (VTE) Assessment and Management
The Newcastle upon Tyne Hospitals NHS Foundation Trust Venous Thromboembolism (VTE) Assessment and Management Version No: 2.0 Effective From: 16 April 2018 Expiry Date: 16 April 2021 Date Ratified: 23
More informationCyclophosphamide INFUSION Infusion 4 Plus
Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename
More informationAre you at risk of blood clots?
Are you at risk of blood clots? DVT (deep vein thrombosis) & PE (pulmonary embolism) Information for patients in hospital or going home from hospital Are you at risk of blood clots? (DVT & PE) This leaflet
More informationCase Presentation. Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008
Case Presentation Cindy Felty MSN, RN, CNP, FCCWS Assistant Professor of Medicine Mayo Clinic March 27, 2008 Acute DVT Case 1- Day 1 68 year old male admitted overnight to hospital for painful acute DVT
More informationCommunity DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres
Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment
More informationUniversity College London Hospitals (UCLH) Preventing venous thromboembolism (VTE)
University College London Hospitals (UCLH) Preventing venous thromboembolism (VTE) Information for adult inpatients and for patients due to be admitted If you need a large print, audio, braille, easy read
More informationBlood clot prevention. A guide for patients and carers
Blood clot prevention A guide for patients and carers Contents Introduction 1 What is a venous thromboembolism (VTE)? 1 What is a deep vein thrombosis (also known as a DVT)? 1 What is a pulmonary embolism
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Venous Thrombo-Embolism Policy YELLOW - Clinical New or
More informationVenous Thromboprophylaxis (VTE) Policy
Venous Thromboprophylaxis (VTE) Policy Document Summary The intention of this policy is to ensure that all adult patients and service users of Cumbria Partnership Foundation NHS Trust are assessed for
More informationSheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines
Sheffield Teaching Hospitals: Pulmonary Hypertension Information for Medical Staff 31/03/2014 Local guidelines Diagnostic pathway - page 2 Iloprost dosing chart and conversion table - page 3-4 Hickman
More informationKEY TO INITIALS OF ALL STAFF COMPLETING THIS ICP Print name Designation Initials Signature date
Forename Surname Unit number Address (including Postcode) NHS Lothian Arrived in.unit for procedure Date: & time: GP Address Religion Ethnic Origin Tel. number Next of Kin: /address Tel. number(s):home
More informationANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION
Apixaban ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES APIXABAN (ELIQUIS ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside a blood
More informationEast Lancashire DVT Local Enhanced Services (LES)
Agenda Item No: 6.5 REPORT TO: PRIMARY CARE COMMITTEE MEETING DATE: 13 September 2017 REPORT TITLE: SUMMARY OF REPORT: REPORT RECOMMENDATIONS: East Lancashire DVT Local Enhanced Services (LES) The paper
More informationStatement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.
THROMBOSIS GROUP Venous thromboembolism (VTE) is a collective term referring to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is defined by the following ICD-10 codes: I80.0-I80.3, I80.8-I80.9,
More informationBest Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism)
Best Practice Guidelines - BPG 7 VTE (Venous Thrombo Embolism) (Venous Thrombo Embolism) 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationProtocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin
Protocol Number: 7 Protocol Title: Ambulatory Initiation and Management of Warfarin for Adults Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Target Patient
More informationClinical Policies Group notified to Quality and Safety Operational Group Approval Date 31/05/2017 Initial Equality Impact Screening
Document Details Title Reducing the Risk of Venous Thromboembolism Policy Trust Ref No 1544-36862 Local Ref (optional) NA This policy is intended to support clinical staff at Shropshire Main points the
More informationPatient Sticker Blood Transfusion Ambulatory Emergency Care Pathway
Patient Sticker Blood Transfusion Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open:
More informationDeep Vein Thrombosis (DVT) - Blood Clots
Patient information Deep Vein Thrombosis (DVT) - Blood Clots i Important information for all patients. Golden Jubilee National Hospital Agamemnon Street Clydebank, G81 4DY (: 0141 951 5000 www.nhsgoldenjubilee.co.uk
More informationANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION
Rivaroxaban ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES RIVAROXABAN (XARELTO ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside
More informationPreventing hospital-acquired blood clots
Preventing hospital-acquired blood clots Haematology Department Patient information leaflet This leaflet explains more about blood clots, which can form after illness and surgery. What are hospital-acquired
More informationCLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage
CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage Suspected Non Variceal upper GI haemorrhage If any features suggest liver disease consult the variceal haemorrhage guideline http://www.rcht.nhs.uk/documentslibrary/royalcornw
More informationVenous Thromboembolism Policy
Venous Thromboembolism Policy Name of Policy Authors Dr Liz Grey-Davies, Consultant Haematologist and Titles: Julianne Rigby, VTE Prevention nurse Dr Christopher Tibbs, Medical Director Miss Renata Hutt,
More informationCamden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly
Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly
More informationSTANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists. Issued by: Contact:
STANDING ORDERS FOR THE MANAGEMENT OF WARFARIN Dose adjustment and INR testing frequency Applicable to: Pharmacists Standing Order used for the Community Pharmacy Anticoagulant Management (CPAM) Service
More informationAn Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015
An Evaluation of the BVH Initiation of warfarin for DVT Sean O Brien Specialist Anticoagulation BMS Oct 2015 Service Provision ADAS is a Consultant led service managed by the Pathology Directorate. Provides
More informationPOLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism. Policy Reference: Version: 1 Status: Approved
POLICY FOR the Assessment, Prevention and Treatment of Venous Thrombo-Embolism Policy Reference: Version: 1 Status: Approved Type: Clinical Policy applies to : All SCH staff within relevant groups; community
More informationAccreditation Program: Long Term Care
ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission
More informationCarePartners Nursing Care Plan Anticoagulant Therapy
CarePartners Nursing Care Plan Anticoagulant Therapy ** If a CarePartners wound pathway, palliative care plan or oncology care plan is being used to guide the patient s care, this Nursing Care Plan may
More informationANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service
ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service Version: Date at ET/PEC: September 2008 Date ratified at Board: Name and
More informationPrevention and Treatment of Venous Thromboembolism (VTE) Policy
CONTROLLED DOCUMENT Prevention and Treatment of Venous Thromboembolism (VTE) Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationInguinal hernia repair integrated care pathway (ICP)
Name Ward Hosp no DOB Affix patient label Inguinal hernia repair integrated care pathway (ICP) Inclusion criteria Patients undergoing inguinal hernia repair aged under 3 months corrected gestational age
More informationOPAT CELLULITIS PATHWAY
OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES
More informationPolicy for Venous Thromboembolism Prevention and Treatment
Policy for Venous Thromboembolism Prevention and Treatment Start date: May 2013 Next Review: May 2015 Committee approval: Endorsed by: Distribution: Location Thrombosis and Thromboprophylaxis Steering
More informationAdverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN
Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural
More informationANTI-COAGULATION MONITORING
ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This
More informationANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION
Dabigatran ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION 1 WHAT DOES DABIGATRAN (PRADAXA ) DO? blood thinner Prevents or treats blood clots This is how a blood clot might look inside
More informationCommunity Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL
Community Clinics Policy and Procedure Manual C - 9 SUBJECT: WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL APPROVED BY: VP Acute & Long Term Care & COO (South) EFFECTIVE DATE: 2007
More informationIndian River Medical Center Policy #: 10.1 Policies and Procedures
Indian River Medical Center Policy #: 10.1 Policies and Procedures Title: ANTICOAGULATION CLINIC Effective Date: Chapter: Pharmacy Reviewed Date: Responsible Person: Director of Pharmacy Revised Date:
More informationDrug Therapy Management
4/17 Welcome to the Centers of Excellence Assessment Becoming an Anticoagulation Center of Excellence gives your service the chance to work as a multidisciplinary team to evaluate your current safety practices
More informationPROTOCOL FOR VENESECTION
PROTOCOL FOR VENESECTION Author: Scope: Date: Dr John de Vos All staff who carry out venesection June 2015 (original June 2006 Dr Janet Shirley) Ratified by: Clinical Audit and Effectiveness Committee
More informationPatient Diary. Enhanced Recovery After Surgery (ERAS) Total Knee Replacement. Helping patients get better sooner after surgery.
Contact numbers If you need any support or advice before or after surgery please do not hesitate to call us. Claire Ward enhanced recovery nurse (Monday Friday 8-4) 07816448518 Ward 12B 01494426398 How
More informationAnticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants
Trust Policy Anticoagulation: Safe prescribing, dispensing and administration of oral and parenteral anticoagulants Purpose Date Version March 2015 2 To manage the inherent risks to patients from the use
More informationSetting up the NOAC Service & Taking it to Primary Care
Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side
More informationVenous Thromboembolism (VTE) Prevention and Management Policy and Procedures
PLEASE NOTE: Whilst the review date for this policy has passed, it is still the current version that should be used by staff. Director of Nursing and Medical Director, April 2014 Venous Thromboembolism
More informationPatient Sticker Syncope Ambulatory Emergency Care Pathway
Patient Sticker Syncope Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open: Monday
More informationPatient Sticker Paracentesis Ambulatory Emergency Care Pathway
Patient Sticker Paracentesis Ambulatory Emergency Care Pathway 1 Patient Sticker Consultant: Dr M Oldfield Consultant: Dr D Harris Lead Nurse: Catie Paterson Ambulatory Emergency Care (AEC) Unit Open:
More informationAfter reading this learning module, the nurse should be able to:
After reading this learning module, the nurse should be able to: Identify the VTE dashboard and understand how to initiate it Identify the requirements of the VTE Core Measure and the nurse s responsibilities
More informationPAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB GP REFERRAL FORM 7
Guidelines for Primary Care Com mmunity-based Clinicians September 2011 IINDEX PAGE NO 1. INTRODUCTION 3 2 WARFARIN INITIATION GUIDELINES... 4 3. WARFARIN FLOWCHART. 5 4 WDHB WARFARIN PATHWAY 6 5 WDHB
More informationNHS INNOVATION SHOWCASE: DVT DIAGNOSIS AND TREATMENT IN PRIMARY CARE
NHS INNOVATION SHOWCASE: DVT DIAGNOSIS AND TREATMENT IN PRIMARY CARE MARCH 2015 IMPROVING OUTCOMES, SAVING LIVES, SAVING MONEY: INNOVATIVE DVT PATHWAYS www.apptg.org.uk CONTENTS Chair s Foreword: Andrew
More informationRef: FOI/CAD/ID December Freedom of Information Act 2000
Ref: FOI/CAD/ID 3663 09 December 2016 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information
More informationContents. Welcome to the Cath Lab P4/5
Contents Welcome to the Cath Lab Preparation Instructions : information to ensure you are ready for your procedure in the Cath Lab, set out for you as questions (Q) and answers (A) How the day will go
More informationLow Molecular Weight Heparins
ril 2014 Low Molecular Weight Heparins FINAL CONSOLIDATED COMPREHENSIVE RESEARCH PLAN September 2015 FINALCOMPREHENSIVE RESEARCH PLAN 2 A. Introduction The objective of the drug class review on LMWH is
More informationAranesp (Darbepoetin) for Renal Anaemia
Aranesp (Darbepoetin) for Renal Anaemia Information for patients, relatives and carers Renal Department York and Scarborough Hospitals Tel: 01904 725370 For more information, please contact: Renal Anaemia
More informationDeveloping Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals
Developing Practice for Thrombosis Prevention in Medical Patients at Queens Medical Centre Campus, Nottingham University Hospitals September 2005 - September 2006 Keywords Venous Thromboembolism Thrombosis
More informationFlexible Sigmoidoscopy with an Enema
Flexible Sigmoidoscopy with an Enema You must read this booklet at least seven days before your test Contents Page What is a flexible sigmoidoscopy? 1 Preparing yourself for a flexible sigmoidoscopy 2
More informationA1. All surgical VTE prevention guidelines are included in the trust policy attached.
Response sent by email 19 December 2016 St Helier Hospital Wrythe Lane Carshalton Surrey SM5 1AA Tel: 020 8296 2000 Direct dial tel: 020 8296 4992 Re: Freedom of Information request - Ref: FOI 3736 Thank
More informationAn Outpatient Program To Treat Deep Venous Thrombosis with Low- Molecular-Weight Heparin
ORIGINAL ARTICLE STEVEN D. PEARSON, MD, MSc RALPH BLAIR, MD ANDREW HALPERT, MD ERIC EDDY, MPH SYLVIA MCKEAN, MD Harvard Vanguard Medical Associates Department of Ambulatory Care and Prevention Harvard
More information27 th May 2011 Anticoagulation in Practice. Dr Jennie Wimperis Consultant Haematologist
Dr Jennie Wimperis Consultant Haematologist What is Click for Clots? Why we set it up? How we set it up? More details of what it contains Thrombosis Risk Assessment Hospital aquired/associated Thrombosis
More informationCroydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement
Shared Care Guideline: Prescribing Agreement Section A: To be completed by the hospital consultant initiating the treatment GP Practice Details: Name: Address: Tel no: Fax no: NHS.net e-mail: Consultant
More informationOxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients
Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.
Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas
More informationThromboprophylaxis in Adult General Medical Patients - Guidelines for Management
Thromboprophylaxis in Adult General Medical Patients - Guidelines for Management Adapted from the Worcestershire Acute Hospitals NHS Trust Guideline WAHT-MED-010 Version: Provider Quality and Safety Committee
More informationINCLUSION CRITERIA. REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.
ACUTE STROKE CLINICAL PATHWAY The clinical pathway is based on evidence informed practice and is designed to promote timely treatment, enhance quality of care, optimize patient outcomes and support effective
More informationNursing care plan for anticoagulation therapy
Nursing care plan for anticoagulation therapy traditional appointments and walk-in services to on-demand, online care. Island Group Administration, Inc; Providing a Better Plan for Healthcare. Chapter
More informationUW MEDICINE PATIENT EDUCATION. Angiography: Kidney Exam. How to prepare and what to expect. What is angiography? DRAFT. Why do I need this exam?
UW MEDICINE PATIENT EDUCATION Angiography: Kidney Exam How to prepare and what to expect This handout explains how to prepare and what to expect when having a kidney exam using angiography. What is angiography?
More informationFast Facts 2018 Clinical Integration Performance Measures
IMPORTANT: LHP providers who do not achieve a minimum CI Score in 2018 will not be eligible for incentive distribution and will be placed on a monitoring plan for the 2019 performance year. For additional
More informationAlso available from Huntleigh Healthcare. Patient Information: Pressure ulcers. Venous leg ulcer: A patient carer guide
Also available from Huntleigh Healthcare Patient Information: Pressure ulcers WoundASSIST TNP therapy: A patient information leaflet Venous leg ulcer: A patient carer guide Lympoedema: A patient carer
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationAlert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector
Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes
More informationInitiation of Warfarin for patients not registered with Provider Practice
Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin
More information*Your Name *Nursing Facility. radiation therapy. SECTION 2: Acute Change in Condition and Factors that Contributed to the Transfer
Gaining information about resident transfers is an important goal of the OPTIMISTC project. CMS also requires us to report these data. This form is where data relating to long stay transfers are to be
More informationOxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services
More informationInpatient Quality Reporting Program
Venous Thromboembolism 2015 Abstraction Guidance Presentation Transcript Moderator: Candace Jackson, RN Inpatient Quality Reporting Support Contract Lead, HSAG Speakers: Denise Krusenoski, MSN, RN, CMSRN,
More informationClinical Check of Prescriptions in Ward Areas
Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy
More informationAmbulatory Emergency Care Pathways. Pulmonary Embolism
Ambulatory Emergency Care Pathways Pulmonary Embolism Effective Date: September 2011 Content Summary Ref Title Description 1 Condition Details Identifies pathway details and clinical sign-off 2 Pathway
More informationComparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs
HEALTH SERVICES RESEARCH FUND HEALTH CARE AND PROMOTION FUND Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs
More informationUW MEDICINE PATIENT EDUCATION. Angiography: Percutaneous or Transjugular Liver Biopsy. How to prepare and what to expect. What is a liver biopsy?
UW MEDICINE PATIENT EDUCATION Angiography: Percutaneous or Transjugular Liver Biopsy How to prepare and what to expect This handout explains how to prepare and what to expect when having a percutaneous
More informationVENOUS THROMBOEMBOLISM POLICY
VENOUS THROMBOEMBOLISM POLICY To be read in conjunction with the DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) Policy, Admission, Transfer and Discharge Policy and Rapid Tranquilisation Policy
More informationCommissioning effective anticoagulation services for the future: A resource pack for commissioners
Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid
More informationTHE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES:
THE PREVENTION AND MANAGEMENT OF VTE IN CARE HOMES: CURRENT STANDARDS IN ENGLAND DECEMBER 2016 www.apptg.org.uk CONTENTS Chair s Foreword: Andrew Gwynne MP 4 Summary of Findings 5 Introduction 6 Transfer
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationINR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA
P A T I E N T I N F O R M A T I O N G U I D E INR Self Testing Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA A Summary INR home testing devices are
More informationContact sheet e.g SW, CPN, Nursing Home, NOK
Date Time Hb Wbc Plts Hct Neuts Na K Urea Creat INR APPT CRP Tot Prot Alb Globulin Bilirubin ALT AlkPhos Gamma Amylase Phoshate Calcium Ca Corr Mag egfr BLOOD RESULTS Adult Major Burns Assessment - Integrated
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They
More informationIntegrated Care Pathway Trans Urethral Resection of the Prostate (TURP /GYRUS/HOLAP/HOLEP)
Integrated Care Pathway Trans Urethral Resection of the Prostate (TURP /GYRUS/HOLAP/HOLEP) Use this pathway for all patients requiring planned surgery for TURP Patient name / Label DOB: Hospital Number
More informationEnhanced Recovery After Surgery (ERAS) Liver Resection Information for patients
Oxford University Hospitals NHS Trust Enhanced Recovery After Surgery (ERAS) Liver Resection Information for patients What is Enhanced Recovery? Enhanced Recovery is a new way of improving the experience
More informationSurvey about Venous Thrombo-Embolism (VTE) Prophylaxis. Nurses
Survey about Venous Thrombo-Embolism (VTE) Prophylaxis Nurses Dear staff member, This is a short survey about venous thromboembolism (VTE) at your hospital organization. Venous Thromboembolism (VTE) is
More informationSentinel Stroke National Audit Programme (SSNAP)
Sentinel Stroke National Audit Programme (SSNAP) Acute organisational audit report This report is for stroke survivors and their families November 2016 2016 1 Contents Contents... 2 Useful Contacts and
More informationLaparoscopic partial nephrectomy
Laparoscopic partial nephrectomy This leaflet is written to give you information and answer questions you may have about your surgery. If you have any further questions, please speak to your doctor or
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationService Specification
Service Specification Level 4 Anticoagulation Management Release: Final Date: 1/1/11 Author: Suzanne Pickering Primary Care Commissioning Manager NHS Derbyshire County Owner: Jackie Pendleton Assistant
More informationReimbursement for Anticoagulation Services
Journal of Thrombosis and Thrombolysis 12(1), 73 79, 2001. # 2002 Kluwer Academic Publishers, Manufactured in The Netherlands. Reimbursement for Anticoagulation Services Paul W. Radensky McDermott, Will
More informationAzathioprine. Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with Azathioprine, March 2012 Page 1 of 6
Azathioprine Shared Care Agreement for the treatment of Ulcerative colitis and Crohn s disease with azathioprine, a copy of which must be supplied by the specialist to the GP at commencement, which will
More informationGENERAL CONSENT TO TREAT
GENERAL CONSENT TO TREAT DATE: PATIENTS NAME: DATE OF BIRTH: MRN: Consent: I request and authorize medical or surgical treatment as may be deemed necessary and appropriate by the physician and his/her
More informationSpecialist Surgery Inpatients Breast Reconstruction Surgery Information for patients
Specialist Surgery Inpatients Breast Reconstruction Surgery Information for patients Your hospital stay This leaflet has been written to give you information about your surgery and what will happen during
More information